Create personalized user journeys with Omnichannel Marketing as a Service.
Empower your marketing operations with AI and Data.
Adopt a future-proof holistic approach to content strategy.
Leverage a suite of professional services for pharma and life sciences.
Develop and enable adaptable pharma and life sciences marketing content.
Enable format-free marketing with content management platform.
The innovation-powered content management platform to produce and distribute high quality digital content
Discover our story, values, and how we're making a positive impact
Explore the heart of our organization and meet the visionary minds
The Viseven team is about respect, diversity, comfortable working conditions, and equal opportunities for everyone. We explore, evolve, and adapt – together.
Pharma and Life Sciences industry is highly regulated, and its products and offerings have far-reaching impacts on the public’s health and well-being. From the ideation stage to the marketing of the drugs, the pharma market employs medical experts, researchers, and thought leaders. These professionals are known as key opinion leaders (KOLs) in the pharma industry.
Key opinion leaders play a critical role in the life sciences industry – pharmaceutical companies often engage them during clinical trials and drug commercialization. However, given the current regulatory approval challenges, many pharma companies seek to collaborate with KOLs medical throughout the entire drug development cycle. The role of KOL in pharma is pivotal as they provide invaluable insights that help manufacturers navigate the regulatory landscape and bring credibility during the marketing phase.
Key opinion leaders in pharmaceuticals are patients, clinicians, physicians, researchers, and other experienced experts who help shape how a new medication is marketed and its features and provide pharmaceutical organizations with valuable feedback about new medicines and technologies. They have become invaluable in the healthcare industry.
Many healthcare professionals opt to become a key opinion leader (KOL) because it allows them to share and increase their knowledge about the latest innovations, better treat their patients, widen their professional circle, and receive handsome compensation.
KOLs can be a valuable source of knowledge for patients and ensure that patients receive the best treatment possible.
KOLs have the potential to reach peers and patients from all over the world. This global perspective helps create other KOL engagement and management activities. Working with KOLs allows you to create referral networks and connect new patients, regardless of location or affiliation.
A KOL’s expertise can help in making a successful clinical treatment. In some cases, a KOL may be the one who coordinates the clinical trials and keeps everything organized, especially when there are multiple study sites involved. Having such an expert on board can help ensure that the process of clinical trials runs smoothly and successfully.
Key opinion leaders in healthcare have a lot of experience, making them influential in their community. That means that KOLs could help create awareness for a new drug and can also be beneficial for pharmaceutical companies to generate turnover, improve patient satisfaction, and increase sales.
KOLs help organizations make precise decisions while purchasing new medicines, like how a rock star’s opinion makes their fans buy more merchandise from a band they love.
A KOL in the pharma industry plays an integral strategic role as they help manufacturers to have the desired impact with their target audience, since they help bring credibility. They can also help companies by providing buy-in at a hospital or health network.
Key opinion leader can often be viewed as the mastermind behind a particular product in the pharma industry, not just a marketable face. They’ve put in the time and research to be recognized by their peers as experts in their field. As a result, they have gained a reputation as a thought leader within their specific niche. Their expert opinions and actions can significantly affect the adoption of a new product/brand or the ability to influence consumer purchasing decisions.
Key opinion leaders in healthcare can fill many different roles, and their skill sets are highly sought after by those in the know. A key opinion leader can be critically important in helping to educate physicians about a new drug. They can provide information about the working of drugs, which patient demographics can benefit the most, and what treatment regimens are most effective. KOLs can also offer their unique insights as early adopters of new therapies, which can help to identify and create brand acceptance in healthcare.
Additionally, pharma brands strive to engage with KOLs with extensive expertise in their target therapeutic areas to assist them in participant recruitment for clinical trials and data analysis. These leaders help to identify the unmet needs of both physicians and patients, allowing companies to produce more effective drugs with fewer side effects. Besides, KOLs have influence over the medical community and, therefore, can help companies boost their marketing efforts.
Correctly identifying KOLs and evaluating their influence and expertise is crucial to developing successful pharma initiatives that engage them. You could use key factors to gauge a KOL’s strength and involvement, including the breadth and depth of their participation, brand adoption, and behaviors. There are different types of KOLs, such as rising stars, innovators, and local, national, and international thought leaders, along with many others. Many KOLs might not even fall under any of these categories. Use these factors to determine which kind of key opinion leader you have encountered or might be looking for:
Before engaging with KOLs, it is imperative to learn about their area of expertise. Do they participate in panel discussions? Have they ever worked in hospices or emergency care? Do they have hands-on experience working with older adults? What kind of academic achievements are they known for? The first thing to do on your list should be to understand their clinical and research interests and contributions
A KOL in healthcare can be an expert in complex conditions associated with increased chances of relapses. For instance, diagnosing and treating such chronic conditions as endometriosis is a time-consuming journey for patients, often involving surgery. However, thought leaders can offer valuable insights, aiding gynecologists in understanding innovative treatments and expediting the recovery process.
Some KOLs might offer treatment themselves or receive patient referrals from all over the world. Collaborating with these experts can be incredibly advantageous, extending the reach and impact of marketing campaigns.
If you need to learn how to leverage AI to improve different processes or even just learn how to adapt any new technology, you might want to connect with KOLs who are early adopters of innovative approaches and treatments. These KOLs are usually proactive in participating in clinical studies and are eager to get involved in early drug assessments. This way, they have a critical role in getting first approvals of medicines and expediting time-to-market.
Pharma companies may also seek KOLs who could refer patients to participate in clinical trials. Their role cannot be underestimated when there are multiple study sites in the trial process. Moreover, they can implement investigator-initiated trials to test alternative approaches to using certain medicines.
If you are ready to start collaborating with industry leaders, your first step should be creating a strong KOL engagement plan. Here is how to do it:
Thought leaders’ engagement in pharma is beneficial for companies because it allows them to generate data, refine strategy, and create persuasive medical and promotional content with the help of an expert. KOL relationships are built on trust and a mutual need for long-term cooperation.
A company should take the time to think about why it needs expertise from opinion leaders and where the business could apply it. Having a clear goal will help you manage KOL interactions better, ensuring that you and the experts you will be working with are on the same page.
Before you start a scientific discussion, interview, or any other form of conversation with your KOLs, make some preparations, starting with the obvious—a list of questions. Consider these questions while preparing:
After that, you can start writing the list of possible questions about the KOL’s experiences and expertise. Remember to keep your questions concise and relevant, and be mindful of your interviewee’s comfort, ensuring you don’t go over the allotted time.
Another thing you can do is set up a communication channel where you can ask follow-up questions, receive real-time feedback, and verify your understanding of the KOLs’ insights. Establish a strong connection with your key opinion leaders so that your collaboration extends beyond occasional interviews and one-off questions. Of course, always seek their consent before expanding communication to ensure they feel comfortable with the arrangement.
Even though all the data you will gather from your experts will have a significant influence, only after a thorough analysis is it possible to turn all the information into actionable insights. How come? First of all, after talking to your KOLs, it’s likely you will have just too much info. Your next goal should be dissecting the gathered insights and pulling out the most important information. Break down insights into different sections and analyze how you can apply each.
When it comes to enhancing KOL management, the keyword is “management”. When managing KOLs, it’s crucial to have the right tools and systems in place that allow for more efficient management. How can you be sure that you have contacted all of your KOLs and asked all the right questions? How can you track all your meetings, responses, and feedback? For all of that, it’s important to have some sort of system that helps you see the full picture, such as CRM systems, communication tools, tracking software, AI-powered platforms, and others. Some great examples of such instruments are eWizard, Salesforce Health Cloud, Knect365, and Microsoft Teams.
Use KPIs and different tracking software to determine how successful your engagement plan is. This way, you will always know if your plan is working and whether you should make any changes or not. Moreover, having set goals and KPIs helps you better understand if your company should be engaging KOLs from other industries, areas of expertise, and backgrounds.
From professional conferences and gatherings to platforms like LinkedIn, it’s possible to find key opinion leaders practically anywhere. To help you narrow down your search, we’ve prepared some tips on finding experts for each stage of drug development:
Experts in this phase mostly focus on finding new drug candidates and conducting preclinical studies. Consider hiring pharma scientists, chemists, biologists, and toxicologists for this stage.
Clinical trials require skill in trial management, understanding of patient recruitment, and regulatory and compliance expertise. Key experts are clinical research associates, biostatisticians, and regulatory affairs specialists.
This stage involves regulatory submissions, market access strategies, and post-approval monitoring. Look for pharmacovigilance experts, market access specialists, and regulatory consultants.
Remember that you can find all types of opinion leaders on academic and research platforms, in KOL databases, expert consulting platforms, expert networks, and professional associations.
Before you start working with opinion leaders, you must identify which experts have influence within your area of interest. To do this, organizations track healthcare professionals who regularly speak at scientific meetings and medical congresses.
They also monitor medical practitioners whose work is published in respected journals and who are frequently cited by media outlets as clinical experts.
KOL identification and mapping are like finding a needle in a haystack. It’s a quantitative way to locate physician leaders who influence the medical community. It’s about finding HCP leaders with the most influence within the pharmaceutical industry.
KOL mapping is vital for pharmaceutical companies because it allows them to weed out physicians who don’t meet their requirements. This categorization process is done based on factors like location, specialty domain, and influence that help these manufacturers collaborate with the most influential person in that vertical.
How can you find the right opinion leaders whose goals and vision align with yours? Here are some practices that can help healthcare companies enhance their KOL management:
Once you have identified your leaders, the next thing you should do before anything else is KOL segmentation. It’s likely that you have different groups of people already, depending on how you met them, their specific roles, and other factors. To achieve maximum efficiency, consider segmenting your KOLs by their experience, media impact, readiness to work with you, level of influence (rising, regional, global), and area of engagement.
Feedback from KOLs in pharma, whether it’s negative or positive, can greatly impact your company and its operations. However, harsh criticism or unfavorable assessment might not always be perceived correctly, but instead seem just like someone trying to judge your business.
If it ever comes to a point where you receive negative feedback you are not ready for, take some time to analyze it and think about how you can use it to improve your products and services. There is a lot to learn from both complaints and appraisals, so instead of brooding over something you didn’t expect to hear, focus on making improvements instead.
Product managers are under a lot of pressure to make decisions quickly. However, by forming relationships with respected experts in various medical divisions, they can gain invaluable ideas that will help them make better decisions and shape their businesses more effectively.
Thus, KOLs offer their expertise throughout the product life cycle and development, among other things. They can share it via various communication channels like live conferences or social media. In other words, using KOL in pharma marketing can be a powerful tool to popularize their product.
If you’re in the health science and medical market, you know that effective KOL management is important to your success and business. After all, engaging the right healthcare thought leaders can make or break your drug development efforts.
KOL management is constantly evolving, so companies must look for new and better ways to interact with key opinion leaders. But if you can stay ahead of the curve, you’ll be in an excellent position to succeed and increase sales.
When KOLs are managed well, they can hugely impact a product’s success – from the early stages of discovery and research to when it hits the market. You can see the benefits in more persuasive medical and marketing materials, quicker patient recruitment for trials, more vital consumer awareness, and even influencing prescribing behaviors. In other words, managed KOLs can be a real game-changer.
When a pharmaceutical company and a Key Opinion Leader work together successfully, it’s a win-win situation. The company gets valuable insights from an expert, and the Key Opinion Leader gets opportunities for networking and professional development, not to mention the chance to share ideas and learn from others. Go ahead and gather conferences and webinars, or create a blog article for social media to combine your brand message with thought leaders’ influence.
KOL in pharma is like the megaphone of the clinical trial world. They help get the word out about trial results and outcomes, which are essential for successful market access and eventual drug product adoption. Consequently, they know the best language to communicate trial outcomes and the most effective platforms to disseminate information to healthcare professionals and patient communities.
Moreover, when they serve as principals or even sub-investigators in clinical trials, they naturally boost the visibility of the trials to their peers and other decision-makers in the healthcare sector. It helps both boost high-quality pharma brands and involve more experts in the hottest topics.
Learn how to engage key opinion leaders in your brand strategy and build effective communication with our experts by your side.
